Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 3Prostatic Neoplasms 2Radiation Injuries 1Precancerous Conditions 1Ovarian Neoplasms 1Neurofibromatosis 1 1Melanoma 1Leukemia, Myeloid, Acute 1Carcinoma, Ovarian Epithelial 1Breast Carcinoma In Situ 1

Interventions

Prednisone 112Docetaxel 87Leuprolide 79enzalutamide 72Abiraterone Acetate 67bicalutamide 53Goserelin 50acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 42Radiotherapy 39abiraterone 28Magnetic Resonance Spectroscopy 27Gonadotropin-Releasing Hormone 24gallium 68 PSMA-11 23apalutamide 22Androgen Antagonists 22luprolide acetate gel depot 21sipuleucel-T 20Radiosurgery 20Triptorelin Pamoate 18cabazitaxel 17cabozantinib 16Radiotherapy, Intensity-Modulated 16Flutamide 16pembrolizumab 15radium Ra 223 dichloride 14Prednisolone 14Nivolumab 14Dutasteride 14Dexamethasone 14Radiation 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Prostatic Neoplasms × Lovastatin × Clear all
NCT01478828 2019-03-27

Pre-Prostatectomy Lovastatin on Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Terminated
2 enrolled 4 charts
Genitourinary

Prostatic Neoplasms

NCT00580970 2016-11-18

Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury

Virginia Commonwealth University

Phase 2 Completed
73 enrolled 7 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡